Literature DB >> 16246554

Hexylitaconic acid: a new inhibitor of p53-HDM2 interaction isolated from a marine-derived fungus, Arthrinium sp.

Sachiko Tsukamoto1, Takushi Yoshida, Hidetaka Hosono, Tomihisa Ohta, Hideyoshi Yokosawa.   

Abstract

A new inhibitor of p53-HDM2 interaction was isolated from a culture of marine-derived fungus, Arthrinium sp. The structure was identified to be (-)-hexylitaconic acid (1) by spectroscopic analysis. The inhibition of p53-HDM2 binding was tested by the ELISA method, and 1 inhibited the binding with an IC(50) value of 50 microg/mL. Although a number of synthetic inhibitors of p53-HDM2 interaction have been reported so far, 1 is the second inhibitor isolated from natural resources.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16246554     DOI: 10.1016/j.bmcl.2005.09.052

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  15 in total

1.  Diverse deep-sea fungi from the South China Sea and their antimicrobial activity.

Authors:  Xiao-Yong Zhang; Yun Zhang; Xin-Ya Xu; Shu-Hua Qi
Journal:  Curr Microbiol       Date:  2013-06-05       Impact factor: 2.188

2.  Hoiamide D, a marine cyanobacteria-derived inhibitor of p53/MDM2 interaction.

Authors:  Karla L Malloy; Hyukjae Choi; Catherine Fiorilla; Fred A Valeriote; Teatulohi Matainaho; William H Gerwick
Journal:  Bioorg Med Chem Lett       Date:  2011-10-24       Impact factor: 2.823

Review 3.  Targeting the ubiquitin pathway for cancer treatment.

Authors:  Jia Liu; Shavali Shaik; Xiangpeng Dai; Qiong Wu; Xiuxia Zhou; Zhiwei Wang; Wenyi Wei
Journal:  Biochim Biophys Acta       Date:  2014-12-04

4.  Therapeutic considerations for Mdm2: not just a one trick pony.

Authors:  Jason A Lehman; Jacob A Eitel; Christopher N Batuello; Lindsey D Mayo
Journal:  Expert Opin Drug Discov       Date:  2008-11       Impact factor: 6.098

5.  Design, synthesis, and evaluation of an alpha-helix mimetic library targeting protein-protein interactions.

Authors:  Alex Shaginian; Landon R Whitby; Sukwon Hong; Inkyu Hwang; Bilal Farooqi; Mark Searcey; Jiandong Chen; Peter K Vogt; Dale L Boger
Journal:  J Am Chem Soc       Date:  2009-04-22       Impact factor: 15.419

Review 6.  Marine pharmacology in 2005-6: Marine compounds with anthelmintic, antibacterial, anticoagulant, antifungal, anti-inflammatory, antimalarial, antiprotozoal, antituberculosis, and antiviral activities; affecting the cardiovascular, immune and nervous systems, and other miscellaneous mechanisms of action.

Authors:  Alejandro M S Mayer; Abimael D Rodríguez; Roberto G S Berlinck; Mark T Hamann
Journal:  Biochim Biophys Acta       Date:  2009-03-19

Review 7.  Pharmacological targets in the ubiquitin system offer new ways of treating cancer, neurodegenerative disorders and infectious diseases.

Authors:  Mariola J Edelmann; Benjamin Nicholson; Benedikt M Kessler
Journal:  Expert Rev Mol Med       Date:  2011-11-17       Impact factor: 5.600

8.  Investigation of Marine-Derived Fungal Diversity and Their Exploitable Biological Activities.

Authors:  Joo-Hyun Hong; Seokyoon Jang; Young Mok Heo; Mihee Min; Hwanhwi Lee; Young Min Lee; Hanbyul Lee; Jae-Jin Kim
Journal:  Mar Drugs       Date:  2015-06-30       Impact factor: 5.118

9.  Microbial Screening Based on the Mizoroki-Heck Reaction Permits Exploration of Hydroxyhexylitaconic-Acid-Producing Fungi in Soils.

Authors:  Mei Sano; Ryoki Yada; Yusuke Nomura; Takahiro Kusukawa; Hiroshi Ando; Keiji Matsumoto; Kazuhito Wada; Tomonari Tanaka; Hitomi Ohara; Yuji Aso
Journal:  Microorganisms       Date:  2020-04-29

Review 10.  Natural products targeting the p53-MDM2 pathway and mutant p53: Recent advances and implications in cancer medicine.

Authors:  Jiang-Jiang Qin; Xin Li; Courtney Hunt; Wei Wang; Hui Wang; Ruiwen Zhang
Journal:  Genes Dis       Date:  2018-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.